A 0 1 0 1 O
negative 2 10 2 10 B-pregnancy
urine 11 16 11 16 I-pregnancy
or 17 19 17 19 I-pregnancy
serum 20 25 20 25 I-pregnancy
pregnancy 26 35 26 35 I-pregnancy
test 36 40 36 40 O
must 41 45 41 45 O
be 46 48 46 48 O
obtained 49 57 49 57 O
within 58 64 58 64 O
14 65 67 65 67 B-upper_bound
days 68 72 68 72 I-upper_bound
prior 73 78 73 78 I-upper_bound
to 79 81 79 81 O
the 82 85 82 85 O
start 86 91 86 91 O
of 92 94 92 94 O
study 95 100 95 100 B-treatment
therapy 101 108 101 108 I-treatment
in 109 111 109 111 O
all 112 115 112 115 O
women 116 121 116 121 B-gender
of 122 124 122 124 O
child 125 130 125 130 O
- 130 131 130 131 O
bearing 131 138 131 138 O
potential 139 148 139 148 O

AST 0 3 149 152 B-clinical_variable
( 4 5 153 154 I-clinical_variable
SGOT)/ALT 5 14 154 163 I-clinical_variable
( 15 16 164 165 I-clinical_variable
SGPT 16 20 165 169 I-clinical_variable
) 20 21 169 170 I-clinical_variable
< 22 23 171 172 O
2.5 23 26 172 175 B-upper_bound
x 27 28 176 177 I-upper_bound
institutional 29 42 178 191 I-upper_bound
upper 43 48 192 197 I-upper_bound
limit 49 54 198 203 I-upper_bound
of 55 57 204 206 I-upper_bound
normal 58 64 207 213 I-upper_bound

Ability 0 7 214 221 O
to 8 10 222 224 O
understand 11 21 225 235 O
and 22 25 236 239 O
follow 26 32 240 246 O
the 33 36 247 250 O
breathing 37 46 251 260 O
instructions 47 59 261 273 O
involved 60 68 274 282 O
in 69 71 283 285 O
the 72 75 286 289 O
respiratory 76 87 290 301 O
gating 88 94 302 308 O
procedure 95 104 309 318 O
or 105 107 319 321 O
to 108 110 322 324 O
tolerate 111 119 325 333 O
compression 120 131 334 345 O
sufficient 132 142 346 356 O
to 143 145 357 359 O
reduce 146 152 360 366 O
fiducial 153 161 367 375 B-clinical_variable
motion 162 168 376 382 I-clinical_variable
to 169 171 383 385 O
< 172 173 386 387 O
= 173 174 387 388 O
5 175 176 389 390 B-upper_bound
mm 176 178 390 392 I-upper_bound

Absolute 0 8 393 401 B-clinical_variable
neutrophil 9 19 402 412 I-clinical_variable
count 20 25 413 418 I-clinical_variable
> 26 27 419 420 O
1,500/µL 27 35 420 428 B-lower_bound

Age 0 3 429 432 B-age
≥18 4 7 433 436 O
years 8 13 437 442 I-lower_bound

Completion 0 10 443 453 O
of 11 13 454 456 O
at 14 16 457 459 O
least 17 22 460 465 O
3 23 24 466 467 B-lower_bound
months 25 31 468 474 I-lower_bound
, 31 32 474 475 O
but 33 36 476 479 O
no 37 39 480 482 O
more 40 44 483 487 O
than 45 49 488 492 O
6 50 51 493 494 B-lower_bound
months 52 58 495 501 I-lower_bound
of 59 61 502 504 O
standard 62 70 505 513 O
induction 71 80 514 523 O
chemotherapy 81 93 524 536 B-treatment
for 94 97 537 540 I-treatment
LAPC 98 102 541 545 I-treatment
, 102 103 545 546 O
which 104 109 547 552 O
may 110 113 553 556 O
include 114 121 557 564 O
FOLFIRINOX 122 132 565 575 B-treatment
or 133 135 576 578 O
gemcitabine 136 147 579 590 B-treatment
and 148 151 591 594 O
nab 152 155 595 598 B-treatment
- 155 156 598 599 I-treatment
paclitaxel 156 166 599 609 I-treatment
, 166 167 609 610 O
preferably 168 178 611 621 O
within 179 185 622 628 O
2 186 187 629 630 B-upper_bound
- 187 188 630 631 I-upper_bound
4 188 189 631 632 I-upper_bound
weeks 190 195 633 638 I-upper_bound
but 196 199 639 642 O
no 200 202 643 645 O
longer 203 209 646 652 O
than 210 214 653 657 O
8 215 216 658 659 B-lower_bound
weeks 217 222 660 665 I-lower_bound

Contraindication 0 16 666 682 O
to 17 19 683 685 O
IV 20 22 686 688 B-allergy_name
contrast 23 31 689 697 I-allergy_name

Creatinine 0 10 698 708 B-clinical_variable
Within 11 17 709 715 O
1.5 18 21 716 719 B-upper_bound
x 22 23 720 721 I-upper_bound
upper 24 29 722 727 I-upper_bound
limit 30 35 728 733 I-upper_bound
of 36 38 734 736 I-upper_bound
normal 39 45 737 743 I-upper_bound

Creatinine 0 10 744 754 B-clinical_variable
clearance 11 20 755 764 I-clinical_variable
> 21 22 765 766 O
60 22 24 766 768 B-lower_bound
mL 25 27 769 771 I-lower_bound
/ 27 28 771 772 I-lower_bound
min 28 31 772 775 I-lower_bound
for 32 35 776 779 O
patients 36 44 780 788 O
with 45 49 789 793 O
creatinine 50 60 794 804 O
levels 61 67 805 811 O
above 68 73 812 817 O
institutional 74 87 818 831 O
normal 88 94 832 838 O

ECOG 0 4 839 843 B-clinical_variable
0 5 6 844 845 B-lower_bound
- 6 7 845 846 O
1 7 8 846 847 B-upper_bound

Histologically 0 14 848 862 O
or 15 17 863 865 O
cytopathologically 18 36 866 884 O
confirmed 37 46 885 894 O
adenocarcinoma 47 61 895 909 B-cancer
of 62 64 910 912 I-cancer
the 65 68 913 916 I-cancer
pancreas 69 77 917 925 I-cancer

Locally 0 7 926 933 O
advanced 8 16 934 942 O
, 16 17 942 943 O
unresectable 18 30 944 956 O
pancreatic 31 41 957 967 B-cancer
cancer 42 48 968 974 I-cancer
as 49 51 975 977 O
confirmed 52 61 978 987 O
by 62 64 988 990 O
the 65 68 991 994 O
multidisciplinary 69 86 995 1012 O
input 87 92 1013 1018 O
from 93 97 1019 1023 O
a 98 99 1024 1025 O
hepatobiliary 100 113 1026 1039 O
surgeon 114 121 1040 1047 O
and 122 125 1048 1051 O
as 126 128 1052 1054 O
defined 129 136 1055 1062 O
on 137 139 1063 1065 O
CT 140 142 1066 1068 B-treatment
as 143 145 1069 1071 O
having 146 152 1072 1078 O
tumor 153 158 1079 1084 B-clinical_variable
abutment 159 167 1085 1093 I-clinical_variable
of 168 170 1094 1096 O
> 171 172 1097 1098 O
180 172 175 1098 1101 B-lower_bound
° 175 176 1101 1102 I-lower_bound
( 177 178 1103 1104 O
> 178 179 1104 1105 O
50 180 182 1106 1108 B-lower_bound
% 182 183 1108 1109 I-lower_bound
) 183 184 1109 1110 O
of 185 187 1111 1113 O
the 188 191 1114 1117 O
circumference 192 205 1118 1131 O
of 206 208 1132 1134 O
the 209 212 1135 1138 O
superior 213 221 1139 1147 O
mesenteric 222 232 1148 1158 O
artery 233 239 1159 1165 O
( 240 241 1166 1167 O
SMA 241 244 1167 1170 O
) 244 245 1170 1171 O
or 246 248 1172 1174 O
celiac 249 255 1175 1181 O
axis 256 260 1182 1186 O
, 260 261 1186 1187 O
unreconstructable 262 279 1188 1205 O
superior 280 288 1206 1214 O
mesenteric 289 299 1215 1225 O
vein 300 304 1226 1230 O
( 305 306 1231 1232 O
SMV 306 309 1232 1235 O
) 309 310 1235 1236 O
or 311 313 1237 1239 O
portal 314 320 1240 1246 O
vein 321 325 1247 1251 O
( 326 327 1252 1253 O
PV 327 329 1253 1255 O
) 329 330 1255 1256 O
involvement 331 342 1257 1268 O

Male 0 4 1269 1273 B-gender
subjects 5 13 1274 1282 I-gender
must 14 18 1283 1287 O
also 19 23 1288 1292 O
agree 24 29 1293 1298 B-contraception_consent
to 30 32 1299 1301 I-contraception_consent
use 33 36 1302 1305 I-contraception_consent
effective 37 46 1306 1315 I-contraception_consent
contraception 47 60 1316 1329 I-contraception_consent
for 61 64 1330 1333 O
the 65 68 1334 1337 O
same 69 73 1338 1342 O
period 74 80 1343 1349 O
as 81 83 1350 1352 O
above 84 89 1353 1358 O

No 0 2 1359 1361 O
evidence 3 11 1362 1370 O
of 12 14 1371 1373 O
distant 15 22 1374 1381 B-cancer
metastasis 23 33 1382 1392 I-cancer
either 34 40 1393 1399 O
prior 41 46 1400 1405 O
to 47 49 1406 1408 O
or 50 52 1409 1411 O
after 53 58 1412 1417 O
induction 59 68 1418 1427 O
chemotherapy 69 81 1428 1440 B-treatment

Pancreatic 0 10 1441 1451 B-clinical_variable
tumor 11 16 1452 1457 I-clinical_variable
size 17 21 1458 1462 I-clinical_variable
≤ 22 23 1463 1464 O
5 24 25 1465 1466 B-upper_bound
cm 26 28 1467 1469 I-upper_bound

Platelets 0 9 1470 1479 B-clinical_variable
> 10 11 1480 1481 O
70,000/µL 11 20 1481 1490 B-lower_bound

Pregnant 0 8 1491 1499 B-pregnancy

This 0 4 1500 1504 O
applies 5 12 1505 1512 O
to 13 15 1513 1515 O
any 16 19 1516 1519 O
woman 20 25 1520 1525 B-gender
who 26 29 1526 1529 O
has 30 33 1530 1533 O
experienced 34 45 1534 1545 O
menarche 46 54 1546 1554 B-treatment
and 55 58 1555 1558 O
who 59 62 1559 1562 O
has 63 66 1563 1566 O
not 67 70 1567 1570 O
undergone 71 80 1571 1580 O
successful 81 91 1581 1591 O
surgical 92 100 1592 1600 O
sterilization 101 114 1601 1614 O
or 115 117 1615 1617 O
is 118 120 1618 1620 O
not 121 124 1621 1624 O
postmenopausal 125 139 1625 1639 O
( 140 141 1640 1641 O
defined 141 148 1641 1648 O
as 149 151 1649 1651 O
amenorrhea 152 162 1652 1662 B-chronic_disease
for 163 166 1663 1666 O
at 167 169 1667 1669 O
least 170 175 1670 1675 O
12 176 178 1676 1678 B-lower_bound
consecutive 179 190 1679 1690 I-lower_bound
months 191 197 1691 1697 I-lower_bound
, 197 198 1697 1698 O
or 199 201 1699 1701 O
women 202 207 1702 1707 B-gender
on 208 210 1708 1710 O
hormone 211 218 1711 1718 B-treatment
replacement 219 230 1719 1730 I-treatment
therapy 231 238 1731 1738 I-treatment
with 239 243 1739 1743 O
serum 244 249 1744 1749 B-clinical_variable
FSH 250 253 1750 1753 I-clinical_variable
levels 254 260 1754 1760 I-clinical_variable
greater 261 268 1761 1768 O
than 269 273 1769 1773 O
35 274 276 1774 1776 B-lower_bound
mIU 277 280 1777 1780 I-lower_bound
/ 280 281 1780 1781 I-lower_bound
mL 281 283 1781 1783 I-lower_bound

Total 0 5 1784 1789 O
bilirubin 6 15 1790 1799 B-clinical_variable
Within 16 22 1800 1806 O
2 23 24 1807 1808 B-upper_bound
x 25 26 1809 1810 I-upper_bound
upper 27 32 1811 1816 I-upper_bound
limit 33 38 1817 1822 I-upper_bound
of 39 41 1823 1825 I-upper_bound
normal 42 48 1826 1832 I-upper_bound

Uncontrolled 0 12 1833 1845 O
intercurrent 13 25 1846 1858 B-chronic_disease
illness 26 33 1859 1866 I-chronic_disease
including 34 43 1867 1876 O
, 43 44 1876 1877 O
but 45 48 1878 1881 O
not 49 52 1882 1885 O
limited 53 60 1886 1893 O
to 61 63 1894 1896 O
, 63 64 1896 1897 O
ongoing 65 72 1898 1905 O
or 73 75 1906 1908 O
active 76 82 1909 1915 B-chronic_disease
infection 83 92 1916 1925 I-chronic_disease
, 92 93 1925 1926 O
symptomatic 94 105 1927 1938 O
congestive 106 116 1939 1949 B-chronic_disease
heart 117 122 1950 1955 I-chronic_disease
failure 123 130 1956 1963 I-chronic_disease
, 130 131 1963 1964 O
unstable 132 140 1965 1973 B-chronic_disease
angina 141 147 1974 1980 I-chronic_disease
pectoris 148 156 1981 1989 I-chronic_disease
, 156 157 1989 1990 O
cardiac 158 165 1991 1998 B-chronic_disease
arrhythmia 166 176 1999 2009 I-chronic_disease
, 176 177 2009 2010 O
or 178 180 2011 2013 O
psychiatric 181 192 2014 2025 B-chronic_disease
illness 193 200 2026 2033 I-chronic_disease
/ 200 201 2033 2034 O
social 201 207 2034 2040 B-chronic_disease
situations 208 218 2041 2051 I-chronic_disease
that 219 223 2052 2056 O
would 224 229 2057 2062 O
limit 230 235 2063 2068 O
compliance 236 246 2069 2079 O
with 247 251 2080 2084 O
study 252 257 2085 2090 O
requirements 258 270 2091 2103 O

